{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:42:14Z","timestamp":1790199734768,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":23,"publisher":"Springer US","isbn-type":[{"value":"9781071631744","type":"print"},{"value":"9781071631751","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-3175-1_34","type":"book-chapter","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:02:13Z","timestamp":1684479733000},"page":"523-531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ADAMTS13 Activity: Screening Test Protocol"],"prefix":"10.1007","author":[{"given":"Gary W.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus B.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"34_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","volume":"66","author":"XL Zheng","year":"2015","unstructured":"Zheng XL (2015) ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med 66:211\u2013225","journal-title":"Annu Rev Med"},{"key":"34_CR2","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","volume":"100","author":"JF Dong","year":"2002","unstructured":"Dong JF, Moake JL, Nolasco L et al (2002) ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 100:4033\u20134039","journal-title":"Blood"},{"key":"34_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/ATVBAHA.113.302547","volume":"34","author":"J Bao","year":"2014","unstructured":"Bao J, Xiao J, Mao Y, Zheng XL (2014) Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner. Arterioscler Thromb Vasc Biol 34:397\u2013407","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"34_CR4","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1055\/s-0038-1660505","volume":"2","author":"LN van der Vorm","year":"2018","unstructured":"van der Vorm LN, Remijn JA, de Laat B, Huskens D (2018) Effects of plasmin on von Willebrand factor and platelets: a narrative review. TH Open 2:e218\u2013e228","journal-title":"TH Open"},{"key":"34_CR5","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","volume":"129","author":"BS Joly","year":"2017","unstructured":"Joly BS, Coppo P, Veyradier A (2017) Thrombotic thrombocytopenic purpura. Blood 129:2836\u20132846","journal-title":"Blood"},{"key":"34_CR6","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","volume":"339","author":"M Furlan","year":"1998","unstructured":"Furlan M, Robles R, Galbusera M et al (1998) von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578\u20131584","journal-title":"N Engl J Med"},{"key":"34_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/bjh.13654","volume":"171","author":"S Hassan","year":"2015","unstructured":"Hassan S, Westwood JP, Ellis D, Laing C, Mc Guckin S, Benjamin S, Scully M (2015) The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP registry. Br J Haematol 171:830\u2013835","journal-title":"Br J Haematol"},{"key":"34_CR8","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1111\/jth.15006","volume":"18","author":"XL Zheng","year":"2020","unstructured":"Zheng XL, Vesely SK, Cataland SR et al (2020) ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost 18:2486\u20132495","journal-title":"J Thromb Haemost"},{"key":"34_CR9","doi-asserted-by":"publisher","first-page":"546","DOI":"10.5858\/arpa.2013-0170-OA","volume":"138","author":"BD Barrows","year":"2014","unstructured":"Barrows BD, Teruya J (2014) Use of the ADAMTS13 activity assay improved the accuracy and efficiency of the diagnosis and treatment of suspected acquired thrombotic thrombocytopenic purpura. Arch Pathol Lab Med 138:546\u2013549","journal-title":"Arch Pathol Lab Med"},{"key":"34_CR10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/trf.13359","volume":"56","author":"NT Connell","year":"2016","unstructured":"Connell NT, Cheves T, Sweeney JD (2016) Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura. Transfusion 56:354\u2013359","journal-title":"Transfusion"},{"key":"34_CR11","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/bjh.15219","volume":"184","author":"W Thomas","year":"2019","unstructured":"Thomas W, Cutler JA, Moore GW, McDonald V, Hunt BJ (2019) The utility of a fast turnaround ADAMTS13 activity in the diagnosis and exclusion of thrombotic thrombocytopenic purpura. Br J Haematol 184:1026\u20131032","journal-title":"Br J Haematol"},{"key":"34_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/rth2.12461","volume":"5","author":"N Beranger","year":"2020","unstructured":"Beranger N, Benghezal S, Joly BS et al (2020) Diagnosis and follow-up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay. Res Pract Thromb Haemost 5:81\u201393","journal-title":"Res Pract Thromb Haemost"},{"key":"34_CR13","unstructured":"Geiter S, Wagner L, Binder NB, Budde U (2021) Evaluation of a new fully automated ADAMTS13 activity assay. Res Pract Thromb Haemost 5(Suppl2):278 abstract PB0353"},{"key":"34_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/jth.15157","volume":"19","author":"EJ Favaloro","year":"2021","unstructured":"Favaloro EJ, Mohammed S, Chapman K et al (2021) A multicenter laboratory assessment of a new automated chemiluminescent assay for ADAMTS13 activity. J Thromb Haemost 19:417\u2013428","journal-title":"J Thromb Haemost"},{"key":"34_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/ijlh.12542","volume":"38","author":"MO Nakashima","year":"2016","unstructured":"Nakashima MO, Zhang X, Rogers HJ, Vengal L, Gibson B Jr, Daly TM, Kottke-Marchant K (2016) Validation of a panel of ADAMTS13 assays for diagnosis of thrombotic thrombocytopenic purpura: activity, functional inhibitor, and autoantibody test. Int J Lab Hematol 38:550\u2013559","journal-title":"Int J Lab Hematol"},{"key":"34_CR16","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/ajh.26241","volume":"96","author":"EJ Favaloro","year":"2021","unstructured":"Favaloro EJ, Pasalic L, Henry B, Lippi G (2021) Laboratory testing for ADAMTS13: utility for TTP diagnosis\/exclusion and beyond. Am J Hematol 96:1049\u20131055","journal-title":"Am J Hematol"},{"key":"34_CR17","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/jth.14815","volume":"18","author":"GW Moore","year":"2020","unstructured":"Moore GW, Meijer D, Griffiths M et al (2020) A multi-center evaluation of TECHNOSCREEN\u00ae ADAMTS-13 activity assay as a screening tool for detecting deficiency of ADAMTS-13. J Thromb Haemost 18:1686\u20131694","journal-title":"J Thromb Haemost"},{"key":"34_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/ijlh.13295","volume":"42","author":"I Mackie","year":"2020","unstructured":"Mackie I, Mancini I, Muia J, Kremer Hovinga J, Nair S, Machin S, Baker R (2020) International Council for Standardization in haematology (ICSH) recommendations for laboratory measurement of ADAMTS13. Int J Lab Hematol 42:685\u2013696","journal-title":"Int J Lab Hematol"},{"key":"34_CR19","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jth.14440","volume":"17","author":"H Rottensteiner","year":"2019","unstructured":"Rottensteiner H, Kaufmann S, Rathgeb A, Kink B, Plaimauer B, Matthiessen P, Hann S, Scheiflinger F (2019) Temperature-dependent irreversible conformational change of recombinant ADAMTS13 upon metal ion chelation. J Thromb Haemost 17:995\u20131002","journal-title":"J Thromb Haemost"},{"key":"34_CR20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/jth.12881","volume":"13","author":"AR Hubbard","year":"2015","unstructured":"Hubbard AR, Heath AB, Kremer Hovinga JA (2015) Subcommittee on von Willebrand factor. Establishment of the WHO 1st international standard ADAMTS13, plasma (12\/252): communication from the SSC of the ISTH. J Thromb Haemost 13:1151\u20131153","journal-title":"J Thromb Haemost"},{"key":"34_CR21","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/j.1538-7836.2005.01425.x","volume":"3","author":"B L\u00e4mmle","year":"2005","unstructured":"L\u00e4mmle B, Kremer Hovinga JA, Alberio L (2005) Thrombotic thrombocytopenic purpura. J Thromb Haemost 3:1663\u20131675","journal-title":"J Thromb Haemost"},{"key":"34_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/bjh.12569","volume":"163","author":"N Shah","year":"2013","unstructured":"Shah N, Rutherford C, Matevosyan K, Shen YM, Sarode R (2013) Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). Br J Haematol 163:514\u2013519","journal-title":"Br J Haematol"},{"key":"34_CR23","doi-asserted-by":"publisher","first-page":"E644","DOI":"10.1002\/ajh.24885","volume":"92","author":"A Ayanambakkam","year":"2017","unstructured":"Ayanambakkam A, Kremer Hovinga JA, Vesely SK, George JN (2017) Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 activity 10%-20%. Am J Hematol 92:E644\u2013E646","journal-title":"Am J Hematol"}],"container-title":["Methods in Molecular Biology","Hemostasis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3175-1_34","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:06:45Z","timestamp":1684480005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3175-1_34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071631744","9781071631751"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_34","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"20 May 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}